J.H. Marco Jansen

2.2k total citations
39 papers, 1.5k citations indexed

About

J.H. Marco Jansen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J.H. Marco Jansen has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 20 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in J.H. Marco Jansen's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). J.H. Marco Jansen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). J.H. Marco Jansen collaborates with scholars based in Netherlands, Germany and United States. J.H. Marco Jansen's co-authors include Jeanette H.W. Leusen, C.L.E. Broekkamp, Péter Boross, Maaike Nederend, Jim J. Hagan, Paul W.H.I. Parren, Thomas Valerius, Marije B. Overdijk, Jeroen J. Lammerts van Bueren and John S. Andrews and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

J.H. Marco Jansen

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.H. Marco Jansen Netherlands 21 720 552 478 342 243 39 1.5k
Hirofumi Nishizumi Japan 21 1.2k 1.6× 525 1.0× 202 0.4× 212 0.6× 66 0.3× 36 2.0k
Isabel Lorenzo United States 11 578 0.8× 1.0k 1.8× 68 0.1× 129 0.4× 140 0.6× 19 2.1k
Peter Reinhardt Germany 25 372 0.5× 976 1.8× 59 0.1× 254 0.7× 165 0.7× 62 1.9k
Kristopher D. Marjon United States 14 475 0.7× 315 0.6× 82 0.2× 88 0.3× 159 0.7× 22 1.1k
John R. Adair United Kingdom 16 266 0.4× 628 1.1× 733 1.5× 262 0.8× 44 0.2× 32 1.4k
Eduard Urich Switzerland 13 329 0.5× 603 1.1× 218 0.5× 230 0.7× 44 0.2× 17 1.5k
Chiara Vitale Italy 28 2.1k 3.0× 333 0.6× 45 0.1× 601 1.8× 305 1.3× 49 2.8k
Phung Gip United States 13 581 0.8× 410 0.7× 52 0.1× 195 0.6× 136 0.6× 15 1.3k
Thomas Su United States 15 684 0.9× 969 1.8× 34 0.1× 192 0.6× 46 0.2× 21 2.0k
Karin Franz-Bacon United States 15 1.4k 2.0× 544 1.0× 31 0.1× 603 1.8× 110 0.5× 15 2.4k

Countries citing papers authored by J.H. Marco Jansen

Since Specialization
Citations

This map shows the geographic impact of J.H. Marco Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H. Marco Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H. Marco Jansen more than expected).

Fields of papers citing papers by J.H. Marco Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.H. Marco Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H. Marco Jansen. The network helps show where J.H. Marco Jansen may publish in the future.

Co-authorship network of co-authors of J.H. Marco Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of J.H. Marco Jansen. A scholar is included among the top collaborators of J.H. Marco Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.H. Marco Jansen. J.H. Marco Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foss, Stian, J.H. Marco Jansen, Mitchell Evers, et al.. (2025). Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life. PNAS Nexus. 4(2). pgaf042–pgaf042. 3 indexed citations
2.
Jansen, J.H. Marco, Maaike Nederend, Matthias Peipp, et al.. (2024). The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy. Cancer Immunology Immunotherapy. 73(12). 238–238. 1 indexed citations
3.
Jansen, J.H. Marco, et al.. (2024). Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0. Molecular Cancer Therapeutics. 23(9). 1317–1331. 3 indexed citations
4.
Jansen, J.H. Marco, et al.. (2023). Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains. Cancer Immunology Immunotherapy. 72(9). 3063–3077. 8 indexed citations
5.
Jansen, J.H. Marco, et al.. (2022). Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody. Cells. 11(21). 3406–3406. 13 indexed citations
6.
Evers, Mitchell, Thies Rösner, J.H. Marco Jansen, et al.. (2021). The selection of variable regions affects effector mechanisms of IgA antibodies against CD20. Blood Advances. 5(19). 3807–3820. 11 indexed citations
7.
Treffers, Louise W., Toine ten Broeke, Thies Rösner, et al.. (2019). IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition. Cancer Immunology Research. 8(1). 120–130. 72 indexed citations
8.
Brandsma, Arianne M., Mitchell Evers, Maaike Nederend, et al.. (2019). Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG. Frontiers in Immunology. 10. 704–704. 109 indexed citations
9.
Rösner, Thies, Hanke L. Matlung, J.H. Marco Jansen, et al.. (2018). Immune Effector Functions of Human IgG2 Antibodies against EGFR. Molecular Cancer Therapeutics. 18(1). 75–88. 25 indexed citations
10.
Overdijk, Marije B., J.H. Marco Jansen, Maaike Nederend, et al.. (2016). The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking. The Journal of Immunology. 197(3). 807–813. 196 indexed citations
11.
Brandsma, Arianne M., Toine ten Broeke, Maaike Nederend, et al.. (2015). Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing. Cancer Immunology Research. 3(12). 1316–1324. 39 indexed citations
12.
Lohse, Stefan, Saskia Meyer, Laura A.P.M. Meulenbroek, et al.. (2015). An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo. Cancer Research. 76(2). 403–417. 62 indexed citations
13.
Boross, Péter, J.H. Marco Jansen, Geert van Tetering, et al.. (2014). Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice. Immunology Letters. 160(2). 151–157. 14 indexed citations
14.
Boross, Péter, J.H. Marco Jansen, Jeanette H.W. Leusen, et al.. (2013). Inhibition of the Classical and Lectin Pathway of the Complement System by Recombinant LAIR-2. Journal of Innate Immunity. 6(3). 284–292. 20 indexed citations
15.
Boross, Péter, J.H. Marco Jansen, Agnieszka Pastuła, Cees E. van der Poel, & Jeanette H.W. Leusen. (2012). Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice. Immunology Letters. 143(1). 44–52. 33 indexed citations
16.
Boross, Péter, J.H. Marco Jansen, Simone de Haij, et al.. (2011). The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden. Haematologica. 96(12). 1822–1830. 55 indexed citations
17.
Andrews, John S., et al.. (1994). Effects of imipramine and mirtazapine on operant performance in rats. Drug Development Research. 32(1). 58–66. 11 indexed citations
18.
Hagan, J.J., et al.. (1990). Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems. Psychopharmacology. 101(3). 376–383. 11 indexed citations
19.
Hagan, Jim J., J.H. Marco Jansen, & C.L.E. Broekkamp. (1989). Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology. 98(3). 347–356. 46 indexed citations
20.
Hagan, Jim J., J.H. Marco Jansen, & C.L.E. Broekkamp. (1987). Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine. Psychopharmacology. 93(4). 470–6. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirofumi Nishizumi Breakdown of academic impact, for papers by Isabel Lorenzo Breakdown of academic impact, for papers by Peter Reinhardt Breakdown of academic impact, for papers by Kristopher D. Marjon Breakdown of academic impact, for papers by John R. Adair Breakdown of academic impact, for papers by Eduard Urich Breakdown of academic impact, for papers by Chiara Vitale Breakdown of academic impact, for papers by Phung Gip Breakdown of academic impact, for papers by Thomas Su Breakdown of academic impact, for papers by Karin Franz-Bacon
Rankless by CCL
2026